Sai Life Sciences (544306) Stock Overview
Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 544306 from our risk checks.
544306 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Looking to be second time lucky with a game-changing new product
Key Takeaways Unicycive has successfully completed clinical development of its lead asset, Oxylanthanum Carbonate (OLC). OLC has been designed to improve on current phosphate binders by offering better efficacy, fewer pills, and improved tolerability over alternative treatments for hyperphosphatemia chronic kidney disease patients on dialysis.Read more
Sai Life Sciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹970.50 |
| 52 Week High | ₹1,082.25 |
| 52 Week Low | ₹675.15 |
| Beta | 0 |
| 1 Month Change | -3.12% |
| 3 Month Change | 13.94% |
| 1 Year Change | 34.46% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 26.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| 544306 | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | -3.0% | 1.6% | 2.9% |
| 1Y | 34.5% | 2.5% | 5.5% |
Return vs Industry: 544306 exceeded the Indian Life Sciences industry which returned 2.5% over the past year.
Return vs Market: 544306 exceeded the Indian Market which returned 5.5% over the past year.
Price Volatility
| 544306 volatility | |
|---|---|
| 544306 Average Weekly Movement | 5.9% |
| Life Sciences Industry Average Movement | 6.3% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in IN Market | 10.4% |
| 10% least volatile stocks in IN Market | 4.8% |
Stable Share Price: 544306 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 544306's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 3,401 | Krishnam Kanumuri | www.sailife.com |
Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006.
Sai Life Sciences Limited Fundamentals Summary
| 544306 fundamental statistics | |
|---|---|
| Market cap | ₹205.65b |
| Earnings (TTM) | ₹3.33b |
| Revenue (TTM) | ₹21.70b |
Is 544306 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 544306 income statement (TTM) | |
|---|---|
| Revenue | ₹21.70b |
| Cost of Revenue | ₹6.24b |
| Gross Profit | ₹15.46b |
| Other Expenses | ₹12.13b |
| Earnings | ₹3.33b |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 15.72 |
| Gross Margin | 71.23% |
| Net Profit Margin | 15.34% |
| Debt/Equity Ratio | 18.4% |
How did 544306 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/19 02:48 |
| End of Day Share Price | 2026/04/17 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sai Life Sciences Limited is covered by 9 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mehul Sheth | HDFC Securities Limited |
| Rahul Jeewani | IIFL Research |
| Alok Dalal | Jefferies LLC |